Fermentation macrolides

A number of fungal immunosuppressives have been isolated from fermentation broths and demonstrated to have immunotherapeutic efficacy. Other than cyclosporin (35), two fungal metaboHtes, sirolimus (36), previously known as rapamycin (80), and FK-506 (37) (81) are in various stages of development (see Antibiotics, macrolides). 

Erythromycins are macrolide antibiotics produced by bacterial fermentation. Fluoiination of erythromycin has been studied as a strategy to insure better stability in acidic medium and/or to achieve better bioavailability. An erythromycin, fluorinated at C-8, flurithromycin, was launched several years ago. Its preparation involves an electrophilic fluorination, with CF3OF [119] or with an N-F reagent A/-fluorobenzenesulfonimide (NFSI) [120], of the 8,9-anhydroerythromy-cin-6,9-hemiacetal or of the erythronolide A (Fig. 44). 

Erythromycins are macrolide antibiotics produced by bacterial fermentation. Fluori-nation of erythromycin has been studied to ensure abetter stability in acidic medium and/or a better bioavailability. 

The importance of fermentation-derived antibiotics in veterinary medicine continues to increase. The following two classes of antibiotics, the macrolides and glycosides, were all obtained as metabolites of various Streptomyces species. 

The macrolide class is large and structurally diverse. Macrolides are produced by fermentation of soil microorganisms. Additionally, structural modifications using both chemical and microbiological means have yielded biologically active semisyiiLlielic derivatives. 

Semisynthetic Derivatives. 3 -O-Acyl derivatives have not been found via fermentation, but chemical acylation of the 3/ -hydroxyl group yields products having good antibiotic activity and better pharmacokinetics than the parent macrolides. Two such compounds have been developed 3r/-O-propionyl-leucomycin Af (rokitamycin) C42H 9N015, formerly TMS-19-Q, and 9,3 -di-O-acetylmidecamyein (miokamycin) C HtiNOi . At least part of the in viva improvement was attributed to slower elimination of active metabolites from serum. 

Macrolides are obtained by controlled submerged aerobic fermentations of soil microorganisms. Although species of Streptomyces have dominated, species of Saccharopolyspora, Micromonospora, and Strep toverticillium are also well represented. New techniques such as enzyme-linked immunosorbent assay (ELISA) may prove beneficial for discovering new structures. 

Theriault RJ, Karwowski JP, Jackson M, Girolami RL, Sunga GN, Vojtko CM, Coen LJ (1987) Tiacumicins, A Novel Complex of 18-Membered Macrolide Antibiotics I. Taxonomy, Fermentation and Antibacterial Activity. J Antibiot 40 567... 

A time course of AIV production together with other acyltylosins was studied by cultivating the transformant of MBBF-c (pABHAEH) in a 3-liter-jar fermenter for 10 days. Macrolide productivity was determined by HPLC on a daily basis from the second day. As shown in Fig. 10, production of 3-<9-acetyltylosin... 

R Okamoto, T Fukumoto, K Imafuku, T Kubo, K Kiyoshima, A Takamatsu, T Takeuchi. Screening for 16-membered macrolide-transforming microorganisms. J Ferment Technol 57 519-528, 1979. 

A Arisawa, N Kawamura, K Takeda, H Tsunekawa, K Okamura, R Okamoto. Cloning of the macrolide antibiotic biosynthesis gene acyA, which encodes 3-0-acyltransferase, from Streptomyces thermotolerans and its use for direct fermentative production of a hybrid macrolide antibiotic. Appl Environ Microbiol 60 2657-2660, 1994. 

Macrolide antibiotics, in some instances, may be considered as hydroxy acid derivatives. In addition, many of them have carbohydrates attached, often with unique structural features, as illustrated by erythromycin (20).53 Although some of these antibiotics are semi-synthetic, all are derived by a fermentation process where the antibiotic is formed as a secondary metabolite. This approach, of course, alleviates the need to perform complex carbohydrate chemistry (see Chapter 19). 

Several complex antibiotics are prepared by whole-cell fermentations. Examples are the pencillin antibiotics in which the side chain can be removed and replaced with a synthetic one to enhance activity or stability. Other examples include the macrolide antiobiotics, such as avermectin (56) and erythromycin (57), in which the organism uses an enzyme cassette to build up the seco-chain before cyclization. 

A more recently synthesized derivative, 3,4 -dideoxy-OMT (MC-352 or YM-17K) was found to exhibit in vitro activity that compared favourably with commercially available macrolides [124-126]. The strong in vitro potencies and broad spectrum of macrolides related to OMT and rosaramicin have fueled many efforts to find derivatives with suitable oral efficacy and favourable preclinical features. In addition, new fermentation-derived members of this group such as cirramycin F-1 and F-2, izenamicin, and M-119-a have been isolated [127-129]. However, no OMT-related macrolide has yet emerged as a successful clinical candidate. 

Raw material can be injected into the column without any previous sample treatment, which simplifies the purification procedure. Oka et al. [1] have gathered antibiotics purification by CCC from crude extract and fermentation broth. They have shown that CCC has been successfully applied to the separation of macrolides and of various antibiotics, including various peptide antibiotics which are generally strongly adsorbed to silanol groups on silica gel used in the stationary phase in HPLC. Several CCC types are used, such as DCCC (droplet countercurrent chromatogra-... 

Chemical/Pharmaceutical/Other Class Avermectins are a group of chemically related natural and semisynthetic macrocyclic lactones (macrolide endectocides) produced from the fermentation products of Streptomyces avermitilis. The... 

---